Related Experiment Video
Updated: Jan 8, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Subthalamic DBS-induced diphasic dyskinesias: An overlooked complication?
Arunmozhimaran Elavarasi1, Deepa Dash1, Alfonso Fasano2
1Movement Disorders, Division of Neurology, Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada.
Introduction:
Deep brain stimulation (DBS) has become the standard of care in patients with Parkinson's Disease (PD) experiencing motor fluctuations. The existing literature suggests that deep-brain stimulation (DBS) of the subthalamic nucleus (STN) alleviates levodopa-induced dyskinesias (LID), particularly those associated with high plasma levels of levodopa (peak dose), through medication reduction.
Case Presentation:
We report a case of early-onset PD with motor fluctuations and levodopa-induced peak-dose dyskinesias, who developed an interesting phenomenon of diphasic dyskinesias during the monopolar review of DBS. These dyskinesias resolved when the stimulation amplitude was increased to achieve a more stable 'ON' phase.
Conclusion:
This rare phenomenon suggests that when predominantly lower-limb dyskinesias occur at low current stimulation, increasing stimulation amplitude might improve the excessive movements. Diphasic dyskinesias are often misdiagnosed and under-reported. Future studies should clarify the frequency.
More Related Videos
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
09:46Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
Published on: March 8, 2015
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Parkinson's Disease: Overview